Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Unravelling chronic obstructive pulmonary disease

Unravelling chronic obstructive pulmonary disease

BACK

Unravelling chronic obstructive pulmonary disease

The chronic lung disease COPD affects between 4-10% of Europeans, but about 70% of them are underdiagnosed: a major public health problem. By developing a simulation environment of the respiratory system and creating a decision-support system for clinicians, the European research project SYNERGY-COPD wants to improve diagnosis and management of the disease. The system allows doctors to anticipate the progression of COPD and to determine the most suitable treatment for each COPD patient. Doctors can also make use of a patented algorithm, developed within the project, to assess the quality of the Spirometry tests of their patients.

Three clinical studies were conducted: a retrospective study on two databases of 13 and 5 million patients; a prospective study on over 400 COPD patients; and a third combining these two. The results indicate the high potential of a systems approach to address COPD heterogeneity. Significant knowledge gaps were identified that are relevant to shape strategies to foster 4P Medicine for patients with COPD.

Fermoselle C, Rabinovich R, Ausín P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J, Barreiro E. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J. 2012 Oct;40(4):851-62
Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarría M, Falciani F, Gea J, Cascante M, Barreiro E, Roca J. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med. 2012 Jan 1;52(1):88-94.
Public dissemination: SYNERGY-COPD - http://www.youtube.com/watch?v=RUbC50UoHfQ

IMAGE GALLERY:

NEWS

News The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

On April 10, the European Parliament overwhelmingly backed the reform of General Pharmaceutical Legislation (GPL), marking a pivotal moment in healthcare regulation. With a resounding majority, both the Directive and Regulation were embraced, reflecting a collaborative effort within the ENVI committee.

News The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

Tox by Design is a prominent European toxicological expertise firm specializing in conducting toxicological Risk Assessments (RAs) for various industries such as biotech, pharmaceuticals, cosmetics, medical devices, and API synthesis.

News Marc Horner is the new Avicenna International Affairs Working Group Leader

Marc Horner is the new Avicenna International Affairs Working Group Leader

We are thrilled to announce that Marc Horner, Distinguished Engineer at Ansys, and Global Harmonization Task Force leader at the Avicenna Alliance, has been appointed as the new International Affairs Working Group Leader. Marc was already acting as a close partner of Nathalie Virag, former head of the International Affairs Working Group, recently appointed by Medtronic to prestigious responsibilities.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry